Acetyl-l-carnitine Cognition Meta-analysis: What the Evidence Says

Quick Answer

Acetyl-l-carnitine Cognition Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Detailed information on the composition, sources, functions and other relevant details can be found in Supporting Information : Appendix S1, including figure S1, which summarises the effect of nutraceutical supplements on key biological processes in mitochondria. [Tortajada Juan (2026); evidence level 1]
• In patients with early psychosis, Gaughran et al.found no significant differences between the vitamin D3 and placebo groups in mental health or metabolic outcomes. [Tortajada Juan (2026); evidence level 1]
• Mendelian randomization (MR) presents a causal inference methodology to examine the effect of modifiable exposure on a disease by leveraging genetic variants to provide evidence of robust associations. [Luan Sisi (2025); evidence level 4]
• S1 Our study adopted the TSMR design, an approach that leverages genetic variants as instrumental variables and utilizes summary statistics from two independent samples, which could minimize confounding and reverse causation and provide more robust evidence for causality. [Luan Sisi (2025); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For acetyl-l-carnitine cognition meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Tortajada Juan (2026). Clinical outcomes of mitochondrial‐enhancing nutraceutical supplementation in psychiatric disorders: A systematic review. DOI: 10.1002/gps3.70023. PMCID: PMC13239229. PMID: 42253799. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13239229/
• Luan Sisi (2025). The Effect of Acylcarnitines on Cognitive Function: A Two‐Sample Mendelian Randomization Study. DOI: 10.1002/brb3.70646. PMCID: PMC12224038. PMID: 40607651. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12224038/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.